Domain Summary

natera.com

dedicated to oncology, women’s health, and organ health.

natera.com Quick Summary

Global rank: #45588
Daily visitors: 39.77K
Monthly Visits: 1,193,173
Pageviews per user: 4.61
Registrar Abuse Contact Email:
Registrant Phone:
Rating
TLD: com
IP Address: 108.156.60.16
Organization: Amazon.com, Inc.
Category: Health >
Women's Health
natera.com Icon
natera.com
Last Status:
Online
Last Updated: 25 day ago
loading

About Website

Click here to check amazing payment natera.com content for United States. Otherwise, check out these important facts you probably never knew about natera.com

dedicated to oncology, women’s health, and organ health.

Visit natera.comRight Arrow
Trust Score DNS Competitors Traffic SSL HTTP Headers WHOIS Reviews SEO

natera.com Trust Score

natera.com is probably legit as the trust score is reasonable. Our algorithm rated natera.com a 100. Although our rating of natera.com is medium to low risk, we encourage you to always vote as the evaluation of the site is done automatically.

The trust rating is high. Might be safe.
Trustscore
100 / 100

What is your feeling about natera.com?

rating 10
rating 20
rating 31
rating 40
rating 51
4.0 / 5 Based on 2 Reviews
View/Add Comments

Which Sites are Alternatives & Competitors to natera.com?

Explore the top alternatives and rivals of natera.com in November 2024, and assess their data relating to website traffic, SEO, Web Server Information, and Whois. Refer to the list below for the best competitors of natera.com, and simply click on each one to delve into their specific details.

Mentioned on Their Website:

  • natera.com
    Renasight Patient | Natera

    https://www.natera.com/organ-health/renasight-genetic-testing/patients/

    Commitment to affordability. We welcome all insurance plans and provide affordable testing through a variety of payment methods. Natera offers discounted self-pay pricing and financial assistance through our compassionate care program. The Natera team is here to help you with any billing or reimbursement questions at +1 650.425.4005.

  • natera.com
    Signatera Patient IO monitoring | Natera

    https://www.natera.com/oncology/signatera-advanced-cancer-detection/patients/io-monitoring/

    Learn how Signatera™ works. A one-time analysis of both blood and tissue determines your unique set of tumor mutations. The test is custom-built and personalized for you. Signatera™ detects the presence or absence of cancer each time it is ordered as part of your routine follow-up blood tests.

  • businesswire.com
    Natera’s Landmark RenaCARE Study Demonstrates

    https://www.businesswire.com/news/home/20231102763643/en/Natera%E2%80%99s-Landmark-RenaCARE-Study-Demonstrates-Significant-Diagnostic-and-Clinical-Utility-of-Renasight%E2%84%A2-in-Chronic-Kidney-Disease

    Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, announced that the Journal of the American Society of Nephrology recently publi

  • finance.yahoo.com
    Natera Launches Differentiated New Feature for Prospera™ …

    https://finance.yahoo.com/news/natera-launches-differentiated-feature-prospera-110000809.html

    AUSTIN, Texas, June 17, 2024--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA (cfDNA) and genetic testing, today announced the launch of …

  • natera.com
    Job Openings | Natera

    https://www.natera.com/company/careers/job-openings/

    Women’s Health. TESTS. Horizon – Advanced Carrier Screening; Panorama – Noninvasive Prenatal Testing (NIPT); Empower – Hereditary Cancer Test; Vistara – Single-Gene NIPT; Anora – Miscarriage Test; Spectrum – Preimplantation Genetics; Vasistera – Limited Noninvasive Prenatal Testing (NIPT); FOR PATIENTS. Pricing and Billing Information; …

  • investor.natera.com
    Natera Submits First PMA Module to the FDA for Signatera™

    https://investor.natera.com/news/news-details/2023/Natera-Submits-First-PMA-Module-to-the-FDA-for-Signatera/default.aspx

    AUSTIN, Texas-- (BUSINESS WIRE)-- Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced the submission of the first …

  • natera.com
    Signatera for Patients | Natera

    https://www.natera.com/oncology/signatera-advanced-cancer-detection/patients/

    Signatera™ is a custom-designed ctDNA test that is personalized to each patient’s set of tumor mutations and can identify earlier than traditional tools that may indicate cancer is still present. Knowing this information can help you have a more informed discussion with your doctor regarding your treatment journey.

  • stockhouse.com
    2024-06-17 | Natera Launches Differentiated New Feature

    https://stockhouse.com/news/press-releases/2024/06/17/natera-launches-differentiated-new-feature-for-prospera-tm-heart-test-enhancing

    About Natera. Natera™ is a global leader in cell-free DNA and genetic testing, dedicated to oncology, women’s health, and organ health. We aim to …

  • natera.com
    Renasight Clinicians | Natera

    https://www.natera.com/organ-health/renasight-genetic-testing/clinicians/

    Commitment to affordability. We welcome all insurance plans and provide affordable testing through a variety of payment methods. Natera offers discounted self-pay pricing and financial assistance through our compassionate care program. The Natera team is here to help you with any billing or reimbursement questions at +1 650.425.4005.

  • natera.com
    Signatera research pipeline | Natera

    https://www.natera.com/oncology/signatera-advanced-cancer-detection/research-pipeline/

    Date: Wednesday, May 29th, 2024Time: 8:00 AM – 9:00 AM PT (60-minute webinar) Our expert speakers will discuss the latest data from recent publications and SGO 2024 supporting the use of ctDNA in gynecologic cancer clinical practice and trials. This will be followed by a panel discussion on the future directions and implications for drug ...

  • natera.com
    Empower Patient Brochure - natera.com

    https://www.natera.com/resource-library/empower/empower-patient-brochure/

    Empower Patient Brochure. July 16, 2021. Empower analyzes your genes to determine your risk for common hereditary cancers. Download PDF. Expand Fullscreen.

  • investor.natera.com
    Natera, Inc. | Financials - Annual Reports

    https://investor.natera.com/financials/annual-reports/default.aspx

    Send Email to [email protected] . Quick Links. Quarterly Results; SEC Filings; Investor FAQs; Investor Email Alerts. To opt-in for investor email alerts, please enter your email address in the field and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address.

  • my.natera.com
    Unified patient portal - Natera

    https://my.natera.com/users/edit

    You previously logged in with your Natera account. Email Address *. Password *

  • natera.com
    Genetic Testing for Kidney Disease – Renasight - Natera

    https://www.natera.com/organ-health/renasight-genetic-testing/

    Renasight. Kidney gene panel. Renasight is a test to determine if there is a genetic cause for an individual’s kidney disease or if there is an increased hereditary risk due to family history. The test uses a blood or saliva sample to test 385 genes associated with chronic kidney disease (CKD). Results are available in approximately 3 weeks.

  • natera.com
    Natera Portal Hub | Natera

    https://www.natera.com/natera-portal-hub/

    Natera Portal Hub is a platform that connects you to different Natera portals for women's health, oncology, organ health, and Constellation. You can check on your testing results, …

  • my.natera.com
    Unified patient portal - my.natera.com

    https://my.natera.com/home

    Unified patient portal. Already a member? Log In. Continue with Google. Continue with Apple. By continuing, you are accepting our Terms of Use and Privacy Policy. Or. Email …

  • my.natera.com
    Natera - Unified patient portal

    https://my.natera.com/

    You previously logged in with your Google account. Continue with Google. Use the same login method

  • natera.com
    Natera Reports Fourth Quarter and Full Year 2023 Financial Results

    https://www.natera.com/company/news/natera-reports-fourth-quarter-and-full-year-2023-financial-results/

    Loss from operations for the full year 2023 was $446.2 million compared to $541.0 million in 2022. Natera reported a net loss for the fourth quarter of 2023 of $78.0 million, or ($0.65) per diluted share, compared to a net loss of $142.6 million, or ($1.37) per diluted share, for the same period in 2022. Weighted average shares outstanding were ...

  • natera.com
    Signatera FAQ | Natera

    https://www.natera.com/oncology/signatera-advanced-cancer-detection/faq/

    Signatera. Transforming the management of cancer with personalized testing. Signatera™ is a highly sensitive and personalized molecular residual disease assay (MRD) using circulating tumor DNA (ctDNA), custom designed for each patient to help identify relapse earlier than standard of care tools. Overview. Patient Information.

  • en.wikipedia.org
    Natera - Wikipedia

    https://en.wikipedia.org/wiki/Natera

    Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA (cfDNA) testing technology, with a focus on women’s health, …

  • natera.com
    Comprehensive Screening Options from Horizon | Natera

    https://www.natera.com/womens-health/horizon-advanced-carrier-screening/what-it-screens/

    Comprehensive screening options from Horizon. For a list of detection rates and carrier rates, please call Natera at 650-249-9090 and ask to speak to one of our board-certified genetic counselors. Filter Screenings.

  • reuters.com
    CareDx owes Natera $96 mln in genetic-testing patent case, US …

    https://www.reuters.com/legal/litigation/caredx-owes-natera-96-mln-genetic-testing-patent-case-us-jury-says-2024-01-29/

    A jury in Delaware federal court has awarded genetic-testing company Natera more than $96.3 million in damages after finding that rival CareDx's AlloSure and AlloSeq kidney-transplant tests ...

  • natera.com
    Atypical finding results for clinicians - natera.com

    https://www.natera.com/resource-library/panorama/atypical-finding-results-for-clinicians/

    Panorama. Atypical finding results for clinicians. Atypical finding results for clinicians. Published Date July 26, 2023. . A guide to …

  • natera.com
    Horizon Advanced Carrier Screening | Natera

    https://www.natera.com/womens-health/horizon-advanced-carrier-screening/clinicians/

    Combined incidence. 1 in 634 babies are affected by one of the conditions in the Horizon 14 standard panel 2. Carrier screening is no longer a “nice-to-have”; it’s now best practice — regardless of ethnicity and screening strategy. ACOG recommends carrier screening for all patients either preconception or during pregnancy. 3.

  • natera.com
    Renasight Sponsored Testing | Natera

    https://www.natera.com/info/vertex-sponsored-page-program-overview/

    Natera and Vertex Pharmaceuticals are working together to raise awareness about the genetic causes of kidney disease in the Black community and to reduce the barriers associated with genetic testing. Vertex Pharmaceuticals is sponsoring a no-cost testing program with Natera to provide the Renasight™ genetic test and genetic counseling to ...

  • natera.com
    Empower FAQ | Natera

    https://www.natera.com/oncology/empower-hereditary-cancer-test/faq/

    How do I begin offering Empower in my practice? You can contact Natera by calling 844-778-4700 or emailing [email protected]. Our team can help to set up an account for you. My clinical field specialist gave me Empower kits and now I would like to order more. How can I do that?

  • natera.com
    Fetal RhD | Natera

    https://www.natera.com/info/fetal-rhd/

    Fetal RhD NIPT provides a genotyping test result that determines the RhD gene sequence associated with fetal RhD status for pregnant RHD- (negative) people. Fetal RhD genotype does not always correlate with the phenotype. Panorama™ and Fetal RhD NIPT have been developed and their performance characteristics determined by the CLIA-certified ...

  • investor.natera.com
    Natera, Inc. | Financials - SEC Filings

    https://investor.natera.com/financials/sec-filings/default.aspx

    Date Filing Type Filing Description Download / View. Jun 07, 2024. SC 13G/A. Amended Statement of Ownership. Jun 05, 2024. DEFA14A. Additional Proxy Soliciting Materials (definitive) May 31, 2024. 4.

See More

DNS Lookup

DNS entries, such as A, NS, MX, and TXT records, are crucial for the functioning of the Internet. The A record maps a domain name to an IPv4 address, while the NS record specifies authoritative name servers for a domain. The MX record identifies the mail server responsible for receiving email messages for a domain. Additionally, the TXT record allows for the association of any text information with a domain name. These records play a vital role in ensuring proper communication and connectivity across the internet.

N/A.

natera.com Traffic Analysis

According to global rankings, natera.com holds the position of #45588. It attracts an approximate daily audience of 39.77K visitors, leading to a total of 39885 pageviews. On a monthly basis, the website garners around 1193.17K visitors.

Daily Visitors39.77K
Monthly Visits1193.17K
Pages per Visit4.61
Visit Duration0:04:57
Bounce Rate34.02%
Want complete report?Full SEMrush Report >>
Daily Unique Visitors:
39772
Monthly Visits:
1193173
Pages per Visit:
4.61
Daily Pageviews:
39885
Avg. visit duration:
0:04:57
Bounce rate:
34.02%
Monthly Visits (SEMrush):
1195629

Traffic Sources

SourcesTraffic Share
Social:
2.50%
Paid Referrals:
2.42%
Mail:
1.99%
Search:
28.02%
Direct:
64.77%

Visitors by Country

CountryTraffic Share
United States:
93.45%
Germany:
3.24%
Canada:
0.51%
Nigeria:
0.42%
Australia:
0.33%

SSL Checker - SSL Certificate Verify

An SSL certificate is a digital certificate that ensures a secure encrypted connection between a web server and a user's browser. It provides authentication and encryption to keep data private and protected during transmission. natera.com supports HTTPS, demonstrating their commitment to providing a secure browsing experience for users.

HTTP Headers

HTTP headers are additional segments of data exchanged between a client (e.g. a web browser) and a server during an HTTP request or response. They serve to provide instructions, metadata, or control parameters for the interaction between the client and server.

Status
HTTP/1.1 301 Moved Permanently
Content-Type
text/html
Content-Length
134
Connection
keep-alive
Server
awselb/2.0
Date
Thu, 06 Jun 2024 13:38:38 GMT
Location
https://www.natera.com:443/
X-Cache
Hit from cloudfront
Via
1.1 73d3ff0182f526d6384b20c342c6483a.cloudfront.net (CloudFront)
X-Amz-Cf-Pop
SFO20-C1
X-Amz-Cf-Id
RRQaRub1ZCnEdTyMwndGeBanPuAiSQv5vowQogpGm5dt4JLdp9juoQ==
Age
74776
Content-Security-Policy
upgrade-insecure-requests;
Strict-Transport-Security
max-age=31536000; includeSubDomains; preload
Status
HTTP/1.1 200 OK
Content-Type
text/html; charset=UTF-8
Connection
keep-alive
Date
Thu, 06 Jun 2024 17:56:00 GMT
Set-Cookie
AWSALB=qO5+L9BuJU5uIjbYZNrzz7IN3OgLe1pzgvTz31S0qTwR/ZyApcwIHpZoCtXXy1zybhwzZ+5eZJquvnEySPEksWlfbPxH5bqqYv7i1IRFpIjotd9DgNnc2USU4UPa; Expires=Thu, 13 Jun 2024 17:56:00 GMT; Path=/
Set-Cookie
AWSALBCORS=qO5+L9BuJU5uIjbYZNrzz7IN3OgLe1pzgvTz31S0qTwR/ZyApcwIHpZoCtXXy1zybhwzZ+5eZJquvnEySPEksWlfbPxH5bqqYv7i1IRFpIjotd9DgNnc2USU4UPa; Expires=Thu, 13 Jun 2024 17:56:00 GMT; Path=/; SameSite=None; Secure
Server
nginx/1.24.0
X-Powered-By
PHP/8.2.10-2ubuntu2.1
Last-Modified
Thu, 06 Jun 2024 16:54:10 GMT
Vary
Accept-Encoding
X-Cache
Hit from cloudfront
Via
1.1 f94de31c777bc3bf7b8976bac21b4482.cloudfront.net (CloudFront)
X-Amz-Cf-Pop
SFO20-C1
X-Amz-Cf-Id
4nAPOemMSBWMH2D4WqBVCPSGe-rtzhGfeh2Z-pVvRfqFobwMbDgBLQ==
Age
59334
Content-Security-Policy
upgrade-insecure-requests;
Strict-Transport-Security
max-age=31536000; includeSubDomains; preload

Where is natera.com hosted?

natera.com is likely hosted in various data centers located across different regions worldwide. The current data center mentioned is just one of many where the website may be hosted.

Whois Information

WHOIS protocol used to get domain/IP info. Common for reg details, ownership of a domain/IP. Check natera.com for reg/admin contact info, owner, org, email, phone, creation, and expiration dates.

Domain Updated Date:
Domain Created Date:
Domain Expiry Date:
Domain Name:
Registrar WHOIS Server:
Registrar Abuse Contact Email:
Registrar Abuse Contact Phone:
Domain Registrar:
Domain Owner:

N/A.

SEO Analysis

SEO analysis involves examining the performance of a website, including titles, descriptions, keywords, and website speed. It also includes identifying popular keywords and researching competitor websites to understand their strategies. The analysis aims to optimize the website's visibility and improve its ranking on search engines.

Website Speed Test (Desktop):
0.01 seconds

Website speed is a measurement of how fast the content on your page loads. Website speed is one of many factors involved in the discipline of search engine optimization (SEO), but it is not the only one. In a recent study, the average load time for a web page was 3.21s.

Top Organic Search Terms:
Term Search Volume Traffic Traffic (%)
payment.natera.com 480 0 0%
payment natera.com 390 0 0%

CO-Hosted

CoHosted refers to a situation where multiple domain names (websites) are using the same IP address to point to their respective web servers. They could be owned by different individuals or organizations and may serve entirely different purposes.

nickiswift.com
natera.com

People reviews about natera.com

Very positive reviews

rating 5

Total reviews: 2
Average score: 5 stars

The total score is based on reviews found on the following sites
Scamadviser: 5/5 stars, 2 reviews

Add your review

rating 1 rating 2 rating 3 rating 4 rating 5

Very positive reviews

rating 5

Total reviews: 2
Average score: 5 stars

The total score is based on reviews found on the following sites
Scamadviser: 5/5 stars, 2 reviews


Back Top
Feedback